NCT04022239 2026-01-12
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
Clinical Trials
1 trialsHematopoietic and Lymphoid System Neoplasm × Granulocyte Colony-Stimulating Factor × 90 days × Clear all